CTMX CytomX Therapeutics, Inc.
$1.98
CytomX Therapeutics, Inc. (CTMX) Earnings News
Earnings press releases, previews and reviews for CytomX Therapeutics, Inc. (CTMX), newest first. Our most recent is review: CytomX Matches on EPS, but Varseta-M Data Slips to 2027 Shift the Burden to January.
Thursday
November 5, 2026
9:18 PM ET
CytomX Matches on EPS, but Varseta-M Data Slips to 2027 Shift the Burden to January
Earnings Whispers · Review
Thursday
November 5, 2026
4:15 PM ET
CytomX Therapeutics Announces Q3 2026 Financial Results and Provides Business Update
Thursday
October 29, 2026
12:10 PM ET
CytomX Stock Near Lows as Investors Seek Proof Varsetta M Is on Pivotal Track
Earnings Whispers · Preview
Thursday
October 29, 2026
8:00 AM ET
CytomX Therapeutics to Report Third Quarter 2026 Financial Results on November 5, 2026
Thursday
August 6, 2026
4:15 PM ET
CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update
Thursday
July 30, 2026
8:00 AM ET
CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026